Effect of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of dolasetron and granisetron

Lignende værker

• Impact of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of ondansetron and dexamethasone
  af: Johnson, Brendan, et al.
  Udgivet: (2009)
• Casopitant: a novel NK(1)-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting
  af: Ruhlmann, Christina, et al.
  Udgivet: (2009)
• Effect of single and repeat doses of casopitant on the pharmacokinetics of CYP450 3A4 substrates midazolam and nifedipine
  af: Zamuner, Stefano, et al.
  Udgivet: (2010)
• Pharmacokinetics and central nervous system effects of the novel dual NK(1)/NK(3) receptor antagonist GSK1144814 in alcohol-intoxicated volunteers
  af: te Beek, Erik T, et al.
  Udgivet: (2013)
• Novel Bifunctional Peptides as Opioid Agonists and NK-1 Antagonists
  af: Nair, Padma, et al.
  Udgivet: (2009)